FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017291851> ?p ?o ?g. }

• W2017291851 endingPage "564" @default.
• W2017291851 startingPage "557" @default.
• W2017291851 abstract "Apolipoprotein (apo) C-III is associated with hypertriglyceridemia and progression of cardiovascular disease. Plasma apoC-III is elevated in centrally obese men, and we hypothesized that the kinetics of apoC-III are disturbed in these subjects.We developed a compartmental model to determine very low-density lipoprotein (VLDL) and high-density lipoprotein (HDL) apoC-III metabolic parameters in centrally obese men and investigated the associations with VLDL-apoB and HDL-apoA-I kinetics.Apolipoprotein kinetics was determined using stable isotope techniques and compartmental modelling in 39 centrally obese and 12 nonobese men.Compared with nonobese subjects, centrally obese subjects had increased plasma apoC-III concentration (160 +/- 5 mg/liter vs. 103 +/- 9 mg/liter, P < 0.001), reflecting increased concentrations of both VLDL-apoC-III and HDL-apoC-III. These related to increased production rate (PR) of VLDL-apoC-III (2.12 +/- 0.14 vs. 1.56 +/- 0.29 mg/kg x d, P < 0.05) and reduced fractional catabolic rate (FCR) of both VLDL- and HDL-apoC-III (0.70 +/- 0.02 pools/d vs. 0.82 +/- 0.05 pools/d, P < 0.05). In centrally obese men, VLDL-apoC-III concentration was significantly (P < 0.05) associated with VLDL-apoB concentration and PR as well as HDL-apoA-I FCR and PR and inversely with VLDL-apoB FCR. HDL-apoC-III concentration was significantly (P < 0.05) associated with the concentrations of both VLDL-apoB and HDL-apoA-I, the FCR, and the PR of HDL-apoA-I and inversely with the VLDL-apoB FCR. In multiple regression analysis, both VLDL-apoC-III and HDL-apoC-III concentrations were significantly associated with HDL-apoA-I FCR.In centrally obese men, elevated VLDL-apoC-III and HDL-apoC-III concentrations are a consequence of elevated production and decreased catabolism of VLDL-apoC-III and reduced catabolism of HDL-apoC-III, respectively. These defects are associated with disturbances in VLDL-apoB and HDL-apoA-I metabolism." @default.
• W2017291851 created "2016-06-24" @default.
• W2017291851 creator A5008118241 @default.
• W2017291851 creator A5028287073 @default.
• W2017291851 creator A5055281543 @default.
• W2017291851 creator A5079564889 @default.
• W2017291851 date "2008-02-01" @default.
• W2017291851 modified "2023-09-29" @default.
• W2017291851 title "Plasma Apolipoprotein C-III Transport in Centrally Obese Men: Associations with Very Low-Density Lipoprotein Apolipoprotein B and High-Density Lipoprotein Apolipoprotein A-I Metabolism" @default.
• W2017291851 cites W1502098572 @default.
• W2017291851 cites W1900613292 @default.
• W2017291851 cites W1968332907 @default.
• W2017291851 cites W1970893501 @default.
• W2017291851 cites W1994130325 @default.
• W2017291851 cites W2008281569 @default.
• W2017291851 cites W2017096727 @default.
• W2017291851 cites W2020258883 @default.
• W2017291851 cites W2020885344 @default.
• W2017291851 cites W2021976026 @default.
• W2017291851 cites W2026031981 @default.
• W2017291851 cites W2027083746 @default.
• W2017291851 cites W2029415120 @default.
• W2017291851 cites W2077657002 @default.
• W2017291851 cites W2083811960 @default.
• W2017291851 cites W2085608855 @default.
• W2017291851 cites W2091505484 @default.
• W2017291851 cites W2103369120 @default.
• W2017291851 cites W2109129473 @default.
• W2017291851 cites W2114808162 @default.
• W2017291851 cites W2125628785 @default.
• W2017291851 cites W2142263097 @default.
• W2017291851 cites W2143340286 @default.
• W2017291851 cites W2156763097 @default.
• W2017291851 cites W2167817576 @default.
• W2017291851 cites W2169911638 @default.
• W2017291851 cites W2183213181 @default.
• W2017291851 cites W220565764 @default.
• W2017291851 cites W2337035603 @default.
• W2017291851 cites W2355582620 @default.
• W2017291851 cites W2398870494 @default.
• W2017291851 cites W2414470017 @default.
• W2017291851 cites W298965769 @default.
• W2017291851 cites W4244218181 @default.
• W2017291851 cites W4300831047 @default.
• W2017291851 cites W4323284796 @default.
• W2017291851 doi "https://doi.org/10.1210/jc.2006-2676" @default.
• W2017291851 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2729148" @default.
• W2017291851 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18000086" @default.
• W2017291851 hasPublicationYear "2008" @default.
• W2017291851 type Work @default.
• W2017291851 sameAs 2017291851 @default.
• W2017291851 citedByCount "58" @default.
• W2017291851 countsByYear W20172918512012 @default.
• W2017291851 countsByYear W20172918512013 @default.
• W2017291851 countsByYear W20172918512014 @default.
• W2017291851 countsByYear W20172918512015 @default.
• W2017291851 countsByYear W20172918512016 @default.
• W2017291851 countsByYear W20172918512017 @default.
• W2017291851 countsByYear W20172918512018 @default.
• W2017291851 countsByYear W20172918512019 @default.
• W2017291851 countsByYear W20172918512020 @default.
• W2017291851 countsByYear W20172918512021 @default.
• W2017291851 countsByYear W20172918512022 @default.
• W2017291851 crossrefType "journal-article" @default.
• W2017291851 hasAuthorship W2017291851A5008118241 @default.
• W2017291851 hasAuthorship W2017291851A5028287073 @default.
• W2017291851 hasAuthorship W2017291851A5055281543 @default.
• W2017291851 hasAuthorship W2017291851A5079564889 @default.
• W2017291851 hasBestOaLocation W20172918511 @default.
• W2017291851 hasConcept C126322002 @default.
• W2017291851 hasConcept C134018914 @default.
• W2017291851 hasConcept C185592680 @default.
• W2017291851 hasConcept C2776919658 @default.
• W2017291851 hasConcept C2778163477 @default.
• W2017291851 hasConcept C2778913445 @default.
• W2017291851 hasConcept C2780072125 @default.
• W2017291851 hasConcept C2780541478 @default.
• W2017291851 hasConcept C62746215 @default.
• W2017291851 hasConcept C71924100 @default.
• W2017291851 hasConcept C8243546 @default.
• W2017291851 hasConcept C86803240 @default.
• W2017291851 hasConceptScore W2017291851C126322002 @default.
• W2017291851 hasConceptScore W2017291851C134018914 @default.
• W2017291851 hasConceptScore W2017291851C185592680 @default.
• W2017291851 hasConceptScore W2017291851C2776919658 @default.
• W2017291851 hasConceptScore W2017291851C2778163477 @default.
• W2017291851 hasConceptScore W2017291851C2778913445 @default.
• W2017291851 hasConceptScore W2017291851C2780072125 @default.
• W2017291851 hasConceptScore W2017291851C2780541478 @default.
• W2017291851 hasConceptScore W2017291851C62746215 @default.
• W2017291851 hasConceptScore W2017291851C71924100 @default.
• W2017291851 hasConceptScore W2017291851C8243546 @default.
• W2017291851 hasConceptScore W2017291851C86803240 @default.
• W2017291851 hasIssue "2" @default.
• W2017291851 hasLocation W20172918511 @default.
• W2017291851 hasLocation W20172918512 @default.
• W2017291851 hasLocation W20172918513 @default.
• W2017291851 hasLocation W20172918514 @default.

• next